Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study

Adjunctive Brexpiprazole: A Review in Major Depressive Disorder

Pharmacoeconomic Review Report: Brexpiprazole (Rexulti) - NCBI Bookshelf

Frontiers Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study

Full article: Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

PDF) Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study

What you need to know about Rexulti (Brexpiprazole)

מחקרים על ריקסלטי כטיפול אוגמנטציה בדיכאון (MDD)

REXULTI® (brexpiprazole), MDD

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Mechanism of action of brexpiprazole: comparison with aripiprazole, CNS Spectrums